Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board (ICB) is proceeding with an intention to award a contract for Primary Care Enhanced Services under the Provider Selection Regime regulations, specifically direct award process C. The procurement aims to provide general-practitioner services such as phlebotomy, treatment room services, and specialised drug monitoring, among others. This procurement falls under the health industry category and services are intended to be delivered in the region of UKF3, with Gosberton Medical Centre being the current provider proposed to continue service delivery.
The contract's standstill period began with this notice on 29 August 2025 and representations by providers must be made by 10 September 2025. This process is governed by the Health Care Services Provider Selection Regime Regulations 2023, with the official award yet to be formalised. This tender presents an opportunity for Gosberton Medical Centre, an SME, to further strengthen its position in delivering primary care services within Lincolnshire.
As the procurement is through a limited method without a prior competition call, it highlights a strategic move for service continuity with the existing satisfactory provider. Businesses that specialise in health services and have experience in community-based care and treatments would be well-suited to pursue future similar opportunities. This contract is valued at £97,251 for the period from 1 April 2025 to 31 March 2026, ensuring sustained service provision and potential growth for involved healthcare providers.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS97,251 The provider is an existing provider and the services are existing services.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us